Skip to content

Effect of methylprednisolone pals in treatment of children with refractory epilepsy

The efficasy of treatment with 5 days methylprednisolone pals on electroencephalography in children with refractory epilepsy .

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240615062138N1
Enrollment
50
Registered
2025-03-02
Start date
2023-03-21
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractory epilepsy. Epilepsy, unspecified, intractable, without status epilepticus

Interventions

Intervention group:This intervention is conducted in patients based on the history and clinical examination of seizures and confirmed in the ideal state of the brain EEG. The method of working is that

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Months to 14 Years

Inclusion criteria

Inclusion criteria: Children who based on history and physical examination and electroencephalogram have epilepsy syndromes such as Infantile spasm, Landau-Kleffner syndrome, seizure disorders with waves like hypsarrythmia or burst suppression pattern

Exclusion criteria

Exclusion criteria: Fever leukocytosis high ESR and CRP positivity of blood culture positivity of covid PCR test unknown metabolic disorders positive PPD test, age under 2 months or age over 15 years cases where corticosteroid use is contraindicated

Design outcomes

Primary

MeasureTime frame
The changes and improvement of EEG before and after receiving methylprednisolone pulse. Timepoint: before the start of the intervention and one day after receiving the intervention and 6, 12, 18, 24 months after the intervention. Method of measurement: Questionnaire and reading and comparison of EEGs by a specialist in pediatric neurology and a specialist in pediatric neurology and electrophysiology and epilepsy fellowship.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKhatereh Bagheramiri

Shahid Beheshti University of Medical Sciences

Khatereh.bagheramiri@gmail.com+98 911 210 6334

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026